(Q35787609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Pharmacogenetics and inflammatory bowel disease: progress and prospects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

29 December 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

Jack Satsangi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Charlie Lees

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

148-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15168816%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenetics and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Individualising HIV treatment--pharmacogenetics and immunogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Glucocorticoid receptor variants: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Predictors of response to infliximab in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Using haplotype blocks to map human complex trait loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

High-resolution haplotype structure in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenetics in the laboratory and the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Genomics. New mapping project splits the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

The molecular classification of the clinical manifestations of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Genetic markers may predict disease behavior in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Chemosensitivity prediction by transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Molecular profiling of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200403000-00014